[Immunotherapy for head and neck cancer : Highlights of the 2019 ASCO Annual Meeting].
Sign Up to like & getrecommendations! Published in 2019 at "HNO"
DOI: 10.1007/s00106-019-00761-8
Abstract: BACKGROUND In the field of immunotherapy of head and neck squamous cell carcinoma (HNSCC), a high level of study activity can still be observed. The results of the Keynote-048 study on first-line therapy with pembrolizumab were… read more here.
Keywords: meeting; immunotherapy head; study; pembrolizumab ... See more keywords
Immunotherapy for Head and Neck Cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Hematology/oncology clinics of North America"
DOI: 10.1016/j.hoc.2018.12.006
Abstract: The immune system has a vital role in the development, establishment, and progression of head and neck squamous cell carcinoma (HNSCC). Immune evasion of cancer cells leads to progression of HNSCC. An understanding of this… read more here.
Keywords: head; neck cancer; immune; immunotherapy head ... See more keywords